Original Article

Lack of Association Between Chemokine Receptor 5 (CCR5) δ32 Mutation and Pathogenesis of Asthma in Iranian Patients

Authors: Hamid Abousaidi, MD, Reza Vazirinejad, PhD, Mohammad Kazemi Arababadi, PhD, Houshang Rafatpanah, PhD, Ali Akbar Pourfathollah, PhD, Reza Derakhshan, MD, Saeed Daneshmandi, PhD, Gholamhossein Hassanshahi, PhD

Abstract

Background: Chemokines and their receptors are clinically important mediators, as the chemokine receptors are expressed on almost all immune cells. They play pivotal roles in pathogenesis of almost all clinical situations including asthma. Correspondingly, MIP-1α (CCL3), MIP-1β (CCL4), and RANTES (CCL5) are among the important chemokines involved in the pathogenesis of asthma. These chemokines bind to the CCR5 (their related receptor) on the cell surfaces. Attachment of related chemokine ligands to CCR5 plays an important role in the pathogenesis of asthma; hence, this study aimed to analyze δ32 mutations in CCR5 in asthmatic patients.


Material and Methods: This experimental study was undertaken on 162 asthmatic patients and 200 healthy controls during February to June 2008 at Rafsanjan University of Medical Sciences. The Gap-PCR method was applied to analyze the δ32 mutation in the CCR5 gene, and demographic data (eg, age, sex, occupation, socio-economic status) were collected using a questionnaire.


Results: The findings of this study indicated that none of the asthmatic patients exhibited δ32 mutation in CCR5 chemokine receptor while only 3 (1.5%) of controls had the heterozygotic form of this mutation.


Discussion: Several research groups analyzed δ32 mutations in CCR5 in different diseases, including asthma. Some investigations reported a significant relation between asthma and δ32 mutations in CCR5, but there are also many reports which failed to find a relation between asthma and this mutation. Based on the results of this study and others, it seems that the δ32 mutation does not affect the pathogenesis of asthma.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Jin T, Xu X, Hereld D. Chemotaxis, chemokine receptors and human disease. Cytokine 2008;44:1-8.
 
2. Arababadi MK, Naghavi N, Hassanshahi G, et al. Is CCR5-Delta32 mutation associated with diabetic nephropathy in type 2 diabetes? Ann Saudi Med 2009;29:413.
 
3. Yamamoto H, Nagata M, Sakamoto Y. CC chemokines and transmigration of eosinophils in the presence of vascular cell adhesion molecule 1. Ann Allergy Asthma Immunol 2005;94:292-300.
 
4. Herder C, Illig T, Baumert J, et al. RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Eur J Endocrinol 2008;158:R1-R5.
 
5. Balistreri CR, Caruso C, Grimaldi MP, et al. CCR5 receptor: biologic and genetic implications in age-related diseases. Ann N Y Acad Sci 2007;1100:162-172.
 
6. Ungvari I, Tolgyesi G, Semsei AF, et al. CCR5 Delta 32 mutation, Mycoplasma pneumoniae infection, and asthma. J Allergy Clin Immunol 2007;119:1545-1547.
 
7. Chalmet K, Van Wanzeele F, Demecheleer E, et al. Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability-a study of 4 individuals infected with closely related HIV-1 strains. Virology 2008;379:213-222.
 
8. Faure E, Royer-Carenzi M. Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion? Infect Genet Evol 2008;8:864-874.
 
9. Apostolakis S, Baritaki S, Krambovitis E, et al. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population. J Clin Virol 2005;34:310-314.
 
10. Sandford AJ, Zhu S, Bai TR, et al. The role of the C-C chemokine receptor-5 Delta32 polymorphism in asthma and in the production of regulated on activation, normal T cells expressed and secreted. J Allergy Clin Immunol 2001;108:69-73.
 
11. Alam R, York J, Boyars M, et al. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996;153(4 pt 1):1398-1404.
 
12. Zietkowski Z, Tomasiak MM, Skiepko R, et al. RANTES in exhaled breath condensate of stable and unstable asthma patients. Respir Med 2008;102:1198-1202.
 
13. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:405-413.
 
14. Yudin NS, Vinogradov SV, Potapova TA, et al. Distribution of CCR5-delta 32 gene deletion across the Russian part of Eurasia. Hum Genet 1998;102:695-698.
 
15. Martinson JJ, Chapman NH, Rees DC, et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997;16:100-103.
 
16. Lucotte G. Frequencies of 32 base pair deletion of the (Delta 32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: a comparative analysis. Infect Genet Evol 2002;1:201-205.
 
17. Wichukchinda N, Nakayama EE, Rojanawiwat A, et al. Effects of CCR2 and CCRS polymorphisms on HIV-1 infection in Thai females. J Acquir Immune Defic Syndr 2008;47:293-297.
 
18. Kaur G, Singh P, Rapthap CC, et al. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians. Hum Immunol 2007;68:454-461.
 
19. Mitchell TJ, Walley AJ, Pease JE, et al. Delta 32 deletion of CCR5 gene and association with asthma or atopy. Lancet 2000;356:1491-1492.
 
20. Kurashima K, Mukaida N, Fujimura M, et al. Increase of chemokine levels in sputum precedes exacerbation of acute asthma attacks. J Leukoc Biol 1996;59:313-316.
 
21. Ying S, Taborda-Barata L, Meng Q, et al. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 1995;181:2153-2159.
 
22. Hall IP, Wheatley A, Christie G, et al. Association of CCR5 delta32 with reduced risk of asthma. Lancet 1999;354:1264-1265.
 
23. Cruikshank WW, Long A, Tarpy RE, et al. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am J Respir Cell Mol Biol 1995;13:738-747.
 
24. Lukacs NW, Strieter RM, Warmington K, et al. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 1997;158:4398-4404.